Current performance may be lower or higher than the quoted past performance, which cannot guarantee future results. Share price, principal value, and return will vary, and you may have a gain or loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. The "before sales charge" performance does not reflect the current maximum sales charges, which we explain below. If performance did reflect the charges, it would be lower. The "after sales charge" performance (or returns at public offering price) varies by share class and fund. For class A and class M shares, the current maximum initial sales charges are 5.75% and 3.50% for equity funds and 4.00% and 3.25% for income funds, respectively (with these exceptions: 2.25% for class A of Putnam Floating Rate Income Fund, Short-Term Municipal Income, Short Duration Bond Fund, and Fixed Income Absolute Return Fund). Class B share performance reflects the applicable contingent deferred sales charge (CDSC), which is 5% in the first year, declines to 1% in the sixth year, and is eliminated thereafter (except for Putnam Floating Rate Income Fund, Putnam Short Duration Bond Fund, and Putnam Fixed Income Absolute Return Fund; for these funds, the CDSC is 1% in the first year, declines to 0.5% in the second year, and is eliminated thereafter). Class C share performance reflects a 1% CDSC the first year that is eliminated thereafter. Performance for class B, C, M, N, R, and Y shares prior to their inception is derived from the historical performance of class A shares by adjusting for the applicable sales charge (or CDSC) and, except for class Y shares, the higher operating expenses for such shares (note, for two funds — Putnam Tax-Free High Yield Fund and Putnam Strategic Intermediate Municipal Fund performance prior to inception is based on the historical performance of class B shares). Performance for class A, C, R6, and Y shares of Putnam Mortgage Opportunities Fund before their inception is derived from the historical performance of class I shares, which has been adjusted for the applicable sales charge (or CDSC) and the higher operating expenses for such shares. The "after sales charge" performance (at public offering price) for class N shares reflects the current maximum initial sales charge of 1.50%. Class R, R3, R4, R5, and R6 shares, which are available to qualified employee-benefit plans only, are sold without an initial sales charge and have no CDSC. Class Y shares are generally only available for corporate and institutional clients and have no initial sales charge. Performance for class R3 and R4 shares prior to their inception is derived from the historical performance of class Y shares by adjusting for the higher operating expenses for such shares. Performance for class R5 shares before their inception is derived from the historical performance of class Y shares, which has not been adjusted for the lower expenses; had it been adjusted, performance would be higher (with the exception of the RetirementReady Maturity, 2025, 2030, 2035, and 2040 Funds, for which performance is derived from the historical performance of class R6 shares and has been adjusted for the higher operating expenses for such shares; and the RetirementReady 2045, 2050, 2055, and 2060 Funds, for which performance is derived from the historical performance of class R6 shares and has not been adjusted for the lower expenses; had it been adjusted, performance would be higher). Performance for class R6 shares before their inception is derived from the historical performance of class Y shares, which has not been adjusted for the lower operating expenses; had it been adjusted, performance would be higher. For a portion of the period, some funds had expenses limitations or had been sold on a limited basis with limited assets and expenses. Had these limits not been in place, performance would be lower.
Active Sustainability
Sustainable Future Fund (Class Y) (PMVYX)
Investing in sustainable solutions
Manager commentary: Many sustainability issues rise in importance for businesses
Mental health: Insights and potential investment implications
The Impact of COVID-19 pandemic on mental health.
In June 2020, the CDC found 41% of respondents reported an adverse mental health condition, with 31% suffering from anxiety or depression.
Read our research (PDF)
Highlights
Objective
The fund seeks long-term capital appreciation.
Strategy and process
- Impact companies The fund invests in companies we believe have strong fundamentals that offer potential solutions to key sustainability challenges.
- Active research process A framework grounded in fundamental research and focused on impact-oriented sustainability solutions drives investment decisions.
- Experienced team An experienced, dedicated sustainable investing team is integrated with Putnam's equity research group.
Fund price |
Yesterday’s close | 52-week high | 52-week low |
|---|---|---|---|
| Net asset value |
$18.64
-1.38% | $-0.26 |
$30.20
11/08/21 |
$18.64
01/27/22 |
Consistency of positive performance over five years
Performance shown does not reflect the effects of any sales charges. Click on the dots to see specific returns in each five-year period as of the date revealed. Note that returns of 0.00% are counted as positive periods. For complete fund performance, please click on the performance tab.
26.06%
Best 5-year annualized return
(for period ending 03/31/14)
-5.20%
Worst 5-year annualized return
(for period ending 03/31/09)
10.11%
Average 5-year annualized return
Fund facts as of 12/31/21
$582.24M
43%
Annually
70
April
746802198 / 1856
04/02/02
Growth
PMVYX
Management team
Literature
Fund documents |
|
| The active edge in sustainable investing (PDF) |
|
| The Pivotal Role of Investors in Worker Financial Security (PDF) | |
| Fund Brochure (PDF) |
|
| Impact Report (PDF) | |
| Investing to thrive (PDF) | |
| Fact Sheet (R6 share) (PDF) | |
| Fact Sheet (YA share) (PDF) |
|
| Summary Prospectus (PDF) |
|
| Statutory Prospectus (PDF) |
|
| Toward racial justice (PDF) | |
| Engagement & Stewardship report (PDF) | |
| ESG Policy (PDF) | |
| Statement of Additional Information (SAI) (PDF) | |
| Annual Report (PDF) |
|
| Semiannual Report (PDF) |
|
| Quarterly Commentary (PDF) | |
| Proxy voting results (Form N-PX) (PDF) | |
| Q&A document (PDF) | |
| Mental health: Insights and investment implications (PDF) | |
| White Paper: Integrated Insights (PDF) |
|
The equity bull market is intact
In our view, despite the elongated pandemic and fears about inflation, the bull market remains intact, supported by strong earnings growth and higher-than-expected P/E multiples applied to those earnings.New medicines and digital tools target mental health
In recent years, there have been several developments for treating mental health. These innovations — which come after decades of slower-paced advances — include novel drugs and digital offerings.Mental health is a business issue: How companies are supporting their employees
Companies are beginning to focus more on mental health at work, and some are offering a wider range of supportive and preventive care.Performance
Total return (%) as of 12/31/21
Annual performance as of 12/31/21
Annualized Total return (%) as of 12/31/21
| Annualized performance | 1 yr. | 3 yrs. | 5 yrs. | 10 yrs. |
|---|---|---|---|---|
| Before sales charge | 6.05% | 28.34% | 16.93% | 15.87% |
| After sales charge | N/A | N/A | N/A | N/A |
| Russell Midcap Growth Index | 12.73% | 27.46% | 19.83% | 16.63% |
| Russell 3000 Value-Russell Midcap Growth Linked Benchmark | 12.73% | 27.46% | 15.99% | 15.40% |
Performance snapshot
| Before sales charge | After sales charge | ||
|---|---|---|---|
| 1 mt. as of 12/31/21 | -2.58% | - | |
| YTD as of 01/27/22 | -19.24% | - | |
Risk-adjusted performance as of 12/31/21
| Alpha (3 yrs.) | 2.71 |
|---|---|
| Sharpe ratio (3 yrs.) | 1.41 |
| Treynor ratio (3 yrs.) | 29.48 |
| Information ratio (3 yrs.) | 0.17 |
Volatility as of 12/31/21
| Standard deviation (3 yrs.) | 19.48% |
|---|---|
| Beta | 0.93 |
| R-squared | 0.93 |
Capture ratio as of 12/31/21
| Up-market (3 yrs.) | 98.16 |
|---|---|
| Down-market (3 yrs.) | 91.35 |
Lipper rankings as of 12/31/21
| Time period | Rank/Funds in category | Percentile ranking |
|---|---|---|
| 1 yr. | 418/493 | 85% |
| 3 yrs. | 253/447 | 57% |
| 5 yrs. | 357/410 | 87% |
| 10 yrs. | 191/290 | 66% |
Morningstar Ratings™ as of 12/31/21
| Time period | Funds in category | Morningstar Rating™ |
|---|---|---|
| Overall | 1116 | |
| 3 yrs. | 1116 | |
| 5 yrs. | 1012 | |
| 10 yrs. | 768 |
Distributions
| Record/Ex dividend date | 12/06/21 |
|---|---|
| Payable date | 12/08/21 |
| Income | -- |
| Extra income | -- |
| Short-term cap. gain | $0.721 |
| Long-term cap. gain | $3.002 |
Lipper rankings are based on total return without sales charge relative to all share classes of funds with similar objectives as determined by Lipper. Past performance is not indicative of future results.
The Morningstar RatingTM for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.
The up-market capture ratio is used to evaluate how well an investment manager performed relative to an index during periods when that index has risen. The ratio is calculated by dividing the manager’s returns by the returns of the index during the up-market, and multiplying that factor by 100. The down-market capture ratio is used to evaluate how well an investment manager performed relative to an index during periods when that index has dropped. The ratio is calculated by dividing the manager’s returns by the returns of the index during the down-market and multiplying that factor by 100.
Compare
See how this fund stacks up against its peers with FundVisualizer®
New to FundVisualizer? Watch tutorials on how to get started.
For more tutorials, please visit fundvisualizer.com
** FundVisualizer comparison based on Putnam fund versus the largest fund in its Morningstar category.
Holdings
| Danaher Corp | 3.12% |
|---|---|
| Adobe | 3.09% |
| Edwards Lifesciences Corp | 2.63% |
| Chipotle Mexican Grill | 2.55% |
| Msci | 2.44% |
| Dynatrace | 2.35% |
| First Republic Bank/Ca | 2.33% |
| Zoetis | 2.33% |
| Thermo Fisher Scientific | 2.25% |
| Koninklijke Dsm Nv | 2.17% |
| Top 10 holdings, percent of portfolio | 25.26% |
| Top 10 holdings as of 12/31/21 | |
|---|---|
| Danaher Corp | |
| Adobe | |
| Edwards Lifesciences Corp | |
| Chipotle Mexican Grill | |
| Msci | |
| Dynatrace | |
| First Republic Bank/Ca | |
| Zoetis | |
| Thermo Fisher Scientific | |
| Koninklijke Dsm Nv | |
| Holdings represent 25.26% of portfolio | |
| Top 10 holdings as of 11/30/21 | |
|---|---|
| Adobe | |
| Danaher Corp | |
| Msci | |
| Edwards Lifesciences Corp | |
| Dynatrace | |
| Chipotle Mexican Grill | |
| First Republic Bank/Ca | |
| Lululemon Athletica | |
| Docusign | |
| Thermo Fisher Scientific | |
| Holdings represent 24.05% of portfolio | |
| Top 10 holdings as of 10/31/21 | |
|---|---|
| Adobe | |
| Danaher Corp | |
| Dynatrace | |
| Sunrun | |
| Edwards Lifesciences Corp | |
| Msci | |
| Chipotle Mexican Grill | |
| Thermo Fisher Scientific | |
| Bio-Rad Laboratories | |
| First Republic Bank/Ca | |
| Holdings represent 23.76% of portfolio | |
| Top 10 holdings as of 09/30/21 | |
|---|---|
| Danaher Corp | |
| Adobe | |
| Dynatrace | |
| Chipotle Mexican Grill | |
| Edwards Lifesciences Corp | |
| Thermo Fisher Scientific | |
| Msci | |
| Bio-Rad Laboratories | |
| Docusign | |
| Sunrun | |
| Holdings represent 24.10% of portfolio | |
| DANAHER CORP SEDOL 2250870 | 3.12% |
|---|---|
| ADOBE INC SEDOL 2008154 | 3.09% |
| EDWARDS LIFESCIENCES CORP SEDOL 2567116 | 2.63% |
| CHIPOTLE MEXICAN GRILL INC SEDOL B0X7DZ3 | 2.55% |
| MSCI INC SEDOL B2972D2 | 2.44% |
| DYNATRACE INC SEDOL BJV2RD9 | 2.35% |
| FIRST REPUBLIC BANK/CA SEDOL B4WHY15 | 2.33% |
| ZOETIS INC SEDOL B95WG16 | 2.33% |
| THERMO FISHER SCIENTIFIC INC SEDOL 2886907 | 2.25% |
| KONINKLIJKE DSM NV SEDOL B0HZL93 | 2.17% |
| TRIMBLE INC SEDOL 2903958 | 2.12% |
| BIO-RAD LABORATORIES-A SEDOL 2098508 | 2.10% |
| LULULEMON ATHLETICA INC SEDOL B23FN39 | 2.09% |
| AZEK CO INC/THE SEDOL BKPVG43 | 2.02% |
| COOPER COS INC/THE SEDOL 2222631 | 1.98% |
| DEXCOM INC SEDOL B0796X4 | 1.95% |
| APPLIED MATERIALS INC SEDOL 2046552 | 1.94% |
| MCCORMICK & CO-NON VTG SHRS SEDOL 2550161 | 1.87% |
| NEXTERA ENERGY INC SEDOL 2328915 | 1.86% |
| NOVOZYMES A/S-B SHARES SEDOL B798FW0 | 1.78% |
| ASML HOLDING NV-NY REG SHS SEDOL B908F01 | 1.74% |
| EURAZEO SE SEDOL 7042395 | 1.74% |
| CROWDSTRIKE HOLDINGS INC - A SEDOL BJJP138 | 1.70% |
| ZEBRA TECHNOLOGIES CORP-CL A SEDOL 2989356 | 1.68% |
| HANNON ARMSTRONG SUSTAINABLE SEDOL B9HHD96 | 1.52% |
| INGEVITY CORP SEDOL BD4LHG4 | 1.52% |
| SEAGEN INC SEDOL BLPK4D2 | 1.51% |
| MESA LABORATORIES INC SEDOL 2553814 | 1.48% |
| SUNRUN INC SEDOL BYXB1Y8 | 1.47% |
| DOCUSIGN INC SEDOL BFYT7B7 | 1.45% |
| ECOLAB INC SEDOL 2304227 | 1.41% |
| REGENERON PHARMACEUTICALS SEDOL 2730190 | 1.41% |
| RESMED INC SEDOL 2732903 | 1.38% |
| EXACT SCIENCES CORP SEDOL 2719951 | 1.38% |
| KORN FERRY SEDOL 2386849 | 1.34% |
| ROPER TECHNOLOGIES INC SEDOL 2749602 | 1.26% |
| BILL.COM HOLDINGS INC SEDOL BKDS4H5 | 1.25% |
| BALL CORP SEDOL 2073022 | 1.24% |
| FLUENCE ENERGY INC SEDOL BMXC0N9 | 1.23% |
| MILLERKNOLL INC SEDOL 2594222 | 1.21% |
| LYFT INC-A SEDOL BJT1RW7 | 1.18% |
| LIBERTY GLOBAL PLC- C SEDOL B8W67B1 | 1.18% |
| CERIDIAN HCM HOLDING INC SEDOL BFX1V56 | 1.17% |
| ON SEMICONDUCTOR SEDOL 2583576 | 1.16% |
| VERRA MOBILITY CORP SEDOL BFXX5X8 | 1.15% |
| VAIL RESORTS INC SEDOL 2954194 | 1.08% |
| BUMBLE INC-A SEDOL BMZ2WT7 | 1.07% |
| ETSY INC SEDOL BWTN5N1 | 1.06% |
| ADVANCED DRAINAGE SYSTEMS IN SEDOL BP7RS59 | 1.05% |
| SHOPIFY INC - CLASS A SEDOL BXDZ9Z0 | 1.02% |
| DIVERSEY HOLDINGS LTD SEDOL BNTJ2L3 | 0.99% |
| HEALTHEQUITY INC SEDOL BP8XZL1 | 0.98% |
| GOODRX HOLDINGS INC-CLASS A SEDOL BMTVQT8 | 0.92% |
| WOLFSPEED INC SEDOL BMBVND9 | 0.91% |
| MASTERCARD INC - A SEDOL B121557 | 0.90% |
| LIGHTSPEED COMMERCE INC SEDOL BMYZ2B9 | 0.86% |
| SOARING EAGLE PIPE P/P | 0.80% |
| BUREAU VERITAS SA SEDOL B28DTJ6 | 0.76% |
| TELADOC HEALTH INC SEDOL BYQRFY1 | 0.75% |
| PINTEREST INC- CLASS A SEDOL BJ2Z0H2 | 0.74% |
| CHEGG INC SEDOL BG6N6K6 | 0.71% |
| LAIRD SUPERFOOD INC SEDOL BN2BDY6 | 0.66% |
| PLANET LABS PBC SEDOL BM8JV32 | 0.60% |
| GREENLIGHT/ENVI PIPE P/P | 0.57% |
| THREDUP INC - CLASS A SEDOL BMFPHK2 | 0.56% |
| SPROUTS FARMERS MARKET INC SEDOL BCGCR79 | 0.52% |
| WARBY PARKER INC-CLASS A SEDOL BLGZN51 | 0.51% |
| ZEVIA PBC-A SEDOL BNLYJG0 | 0.29% |
| ABSCI CORP SEDOL BN94K69 | 0.27% |
| GINKGO BIOWORKS HOLDINGS INC SEDOL BN6KXF0 | 0.22% |
| EUR/USD 03/16/2022 UBS | 0.00% |
| EUR/USD 03/16/2022 JPMCB | -0.00% |
| EUR/USD 03/16/2022 SSBT | -0.00% |
| EUR/USD 03/16/2022 BANKAM | -0.00% |
| GBP/USD 03/16/2022 HSBCB | -0.00% |
| GBP/USD 03/16/2022 BCAP-FX | -0.01% |
| DANAHER CORP SEDOL 2250870 | 3.29% |
|---|---|
| ADOBE INC SEDOL 2008154 | 3.04% |
| DYNATRACE INC SEDOL BJV2RD9 | 2.68% |
| CHIPOTLE MEXICAN GRILL INC SEDOL B0X7DZ3 | 2.55% |
| EDWARDS LIFESCIENCES CORP SEDOL 2567116 | 2.28% |
| THERMO FISHER SCIENTIFIC INC SEDOL 2886907 | 2.25% |
| MSCI INC SEDOL B2972D2 | 2.14% |
| BIO-RAD LABORATORIES-A SEDOL 2098508 | 2.04% |
| DOCUSIGN INC SEDOL BFYT7B7 | 1.92% |
| SUNRUN INC SEDOL BYXB1Y8 | 1.92% |
| FIRST REPUBLIC BANK/CA SEDOL B4WHY15 | 1.91% |
| LULULEMON ATHLETICA INC SEDOL B23FN39 | 1.81% |
| CROWDSTRIKE HOLDINGS INC - A SEDOL BJJP138 | 1.80% |
| TRIMBLE INC SEDOL 2903958 | 1.76% |
| DEXCOM INC SEDOL B0796X4 | 1.74% |
| BALL CORP SEDOL 2073022 | 1.72% |
| COOPER COS INC/THE SEDOL 2222631 | 1.72% |
| KONINKLIJKE DSM NV SEDOL B0HZL93 | 1.70% |
| REGENERON PHARMACEUTICALS SEDOL 2730190 | 1.68% |
| LIGHTSPEED COMMERCE INC SEDOL BMYZ2B9 | 1.65% |
| ASML HOLDING NV-NY REG SHS SEDOL B908F01 | 1.63% |
| ZOETIS INC SEDOL B95WG16 | 1.63% |
| APPLIED MATERIALS INC SEDOL 2046552 | 1.60% |
| SEAGEN INC SEDOL BLPK4D2 | 1.56% |
| EURAZEO SE SEDOL 7042395 | 1.54% |
| RESMED INC SEDOL 2732903 | 1.48% |
| EXACT SCIENCES CORP SEDOL 2719951 | 1.47% |
| EVERBRIDGE INC SEDOL BYY5ZB4 | 1.45% |
| MCCORMICK & CO-NON VTG SHRS SEDOL 2550161 | 1.38% |
| NEXTERA ENERGY INC SEDOL 2328915 | 1.37% |
| HANNON ARMSTRONG SUSTAINABLE SEDOL B9HHD96 | 1.34% |
| INGEVITY CORP SEDOL BD4LHG4 | 1.33% |
| IDEXX LABORATORIES INC SEDOL 2459202 | 1.32% |
| NOVOZYMES A/S-B SHARES SEDOL B798FW0 | 1.31% |
| TELADOC HEALTH INC SEDOL BYQRFY1 | 1.28% |
| GODADDY INC - CLASS A SEDOL BWFRFC6 | 1.27% |
| ON SEMICONDUCTOR CORP SEDOL 2583576 | 1.21% |
| MESA LABORATORIES INC SEDOL 2553814 | 1.18% |
| LYFT INC-A SEDOL BJT1RW7 | 1.14% |
| HEALTHEQUITY INC SEDOL BP8XZL1 | 1.13% |
| CERIDIAN HCM HOLDING INC SEDOL BFX1V56 | 1.11% |
| AZEK CO INC/THE SEDOL BKPVG43 | 1.11% |
| ZEBRA TECHNOLOGIES CORP-CL A SEDOL 2989356 | 1.10% |
| LIBERTY GLOBAL PLC- C SEDOL B8W67B1 | 1.09% |
| ECOLAB INC SEDOL 2304227 | 1.09% |
| INSULET CORP SEDOL B1XGNW4 | 1.08% |
| CHEGG INC SEDOL BG6N6K6 | 1.08% |
| NOMAD FOODS LTD SEDOL BQFJGK5 | 1.06% |
| GOODRX HOLDINGS INC-CLASS A SEDOL BMTVQT8 | 1.04% |
| SOARING EAGLE PIPE P/P | 1.02% |
| HERMAN MILLER INC SEDOL 2594222 | 1.02% |
| ETSY INC SEDOL BWTN5N1 | 1.02% |
| VERRA MOBILITY CORP SEDOL BFXX5X8 | 0.99% |
| DIVERSEY HOLDINGS LTD SEDOL BNTJ2L3 | 0.94% |
| PINTEREST INC- CLASS A SEDOL BJ2Z0H2 | 0.93% |
| BUMBLE INC-A SEDOL BMZ2WT7 | 0.92% |
| VAIL RESORTS INC SEDOL 2954194 | 0.88% |
| ROPER TECHNOLOGIES INC SEDOL 2749602 | 0.82% |
| NEVRO CORP SEDOL BS7K7C9 | 0.79% |
| MASTERCARD INC - A SEDOL B121557 | 0.78% |
| THREDUP INC - CLASS A SEDOL BMFPHK2 | 0.75% |
| NXP SEMICONDUCTORS NV SEDOL B505PN7 | 0.67% |
| WOLFSPEED INC SEDOL BMBVND9 | 0.67% |
| LAIRD SUPERFOOD INC SEDOL BN2BDY6 | 0.60% |
| VERTEX PHARMACEUTICALS INC SEDOL 2931034 | 0.56% |
| WARBY PARKER INC-CLASS A SEDOL BLGZN51 | 0.54% |
| GREENLIGHT/ENVI PIPE P/P | 0.52% |
| NUANCE COMMUNICATIONS INC SEDOL 2402121 | 0.51% |
| 1STDIBS.COM INC SEDOL BNNTVV2 | 0.50% |
| HOLOGIC INC SEDOL 2433530 | 0.50% |
| ZEVIA PBC-A SEDOL BNLYJG0 | 0.50% |
| SHOPIFY INC - CLASS A SEDOL BXDZ9Z0 | 0.47% |
| CLIMATE CHANGE CRISI | 0.38% |
| TREX COMPANY INC SEDOL 2483074 | 0.38% |
| ATLAS CREST INV PIPE P/P | 0.35% |
| GINKGO BIOWORKS HOLDINGS INC SEDOL BN6KXF0 | 0.28% |
| ABSCI CORP SEDOL BN94K69 | 0.25% |
| REMITLY GLOBAL INC SEDOL BNZJHH8 | 0.11% |
| TREASURY BILL 00.0000 10/05/2021 | 0.03% |
| EUR/USD 12/15/2021 BANKAM | 0.02% |
| GBP/USD 12/15/2021 BCAP-FX | 0.01% |
| GBP/USD 12/15/2021 HSBCB | 0.00% |
| EUR/USD 12/15/2021 JPMCB | 0.00% |
| EUR/USD 12/15/2021 SSBT | 0.00% |
| EUR/USD 12/15/2021 UBS | 0.00% |
Portfolio composition as of 12/31/21
| Common stock | 98.50% |
|---|---|
| Cash and net other assets | 1.50% |
Equity statistics as of 12/31/21
| Median market cap | $16.51B |
|---|---|
| Weighted average market cap | $62.33B |
| Price to book | 4.87 |
| Price to earnings | 44.16 |
Fund characteristics will vary over time.
Due to rounding, percentages may not equal 100%.
Consider these risks before investing: The value of investments in the fund's portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including general economic, political, or financial market conditions; investor sentiment and market perceptions; government actions; geopolitical events or changes; and factors related to a specific issuer, geography, industry, or sector. These and other factors may lead to increased volatility and reduced liquidity in the fund's portfolio holdings. Growth stocks may be more susceptible to earnings disappointments, technological obsolescence, falling prices and profits, and the market may not favor growth-style investing. Investments in small and midsize companies increase the risk of greater price fluctuations. International investing involves currency, economic, and political risks. Emerging-market securities have illiquidity and volatility risks. The fund's sustainable and environmental, social, and/or corporate governance (ESG) investment strategy may result in the fund investing in certain types of companies, industries or sectors that the market may not favor. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, which would make the fund more vulnerable to adverse developments affecting those industries or sectors. In evaluating an investment opportunity, we may make investment decisions based on information and data that is incomplete or inaccurate. Due to changes in the products or services of the companies in which the fund invests, the fund may temporarily hold securities that are inconsistent with its sustainable investment criteria. Our investment techniques, analyses, and judgments may not produce the outcome we intend. The investments we select for the fund may not perform as well as other securities that we do not select for the fund. We, or the fund's other service providers, may experience disruptions or operating errors that could have a negative effect on the fund. You can lose money by investing in the fund.
Top industry sectors as of 12/31/21
| Health care | 27.45% |
|---|---|
| Information technology | 24.47% |
| Industrials | 12.13% |
| Materials | 9.11% |
| Financials | 8.59% |
| Consumer discretionary | 8.56% |
| Consumer staples | 3.34% |
| Communication services | 2.99% |
| Utilities | 1.86% |
| Other | 1.50% |
0
The unclassified sector (where applicable) includes exchange traded funds and other securities not able to be classified by sector.
Sectors will vary over time.
Expenses
Expense ratio |
Class A | Class B | Class C | Class R | Class R6 | Class Y |
|---|---|---|---|---|---|---|
| Total expense ratio | 1.02% | 1.77% | 1.77% | 1.27% | 0.66% | 0.77% |
| What you pay | 1.02% | 1.77% | 1.77% | 1.27% | 0.66% | 0.77% |
Sales charge
| Breakpoint | Class A | Class B | Class C | Class R | Class R6 | Class Y |
|---|---|---|---|---|---|---|
| $0-$49,999 | 5.75% / 5.00% | 0.00% / 4.00% | 0.00% / 1.00% | -- | -- | -- |
| $50,000-$99,999 | 4.50% / 3.75% | 0.00% / 4.00% | 0.00% / 1.00% | -- | -- | -- |
| $100,000-$249,999 | 3.50% / 2.75% | -- | 0.00% / 1.00% | -- | -- | -- |
| $250,000-$499,999 | 2.50% / 2.00% | -- | 0.00% / 1.00% | -- | -- | -- |
| $500,000-$999,999 | 2.00% / 1.75% | -- | 0.00% / 1.00% | -- | -- | -- |
| $1M-$4M | 0.00% / 1.00% | -- | -- | -- | -- | -- |
| $4M-$50M | 0.00% / 0.50% | -- | -- | -- | -- | -- |
| $50M+ | 0.00% / 0.25% | -- | -- | -- | -- | -- |
CDSC
| Class A (sales for $1,000,000+) | Class B | Class C | Class R | Class R6 | Class Y | |
|---|---|---|---|---|---|---|
| 0 to 9 mts. | 1.00% | 5.00% | 1.00% | -- | -- | -- |
| 9 to 12 mts. | 1.00% | 5.00% | 1.00% | -- | -- | -- |
| 2 yrs. | 0.00% | 4.00% | 0.00% | -- | -- | -- |
| 3 yrs. | 0.00% | 3.00% | 0.00% | -- | -- | -- |
| 4 yrs. | 0.00% | 3.00% | 0.00% | -- | -- | -- |
| 5 yrs. | 0.00% | 2.00% | 0.00% | -- | -- | -- |
| 6 yrs. | 0.00% | 1.00% | 0.00% | -- | -- | -- |
| 7+ yrs. | 0.00% | 0.00% | 0.00% | -- | -- | -- |
Trail commissions
| Class A | Class B | Class C | Class R | Class R6 | Class Y | |
|---|---|---|---|---|---|---|
| 0.25% | 0.25% | 1.00% | 0.50% | 0.00% | 0.00% | |
| NA | NA | NA | NA | NA | NA | |
| NA | NA | NA | NA | NA | NA |
For sales and trail commission information on purchases over $1 million and participant-directed qualified retirement plans, see a Putnam fund prospectus and the statement of additional information.
The Russell Midcap® Growth Index is an unmanaged index of those companies in the Russell Midcap® Index chosen for their growth orientation. The Russell 3000® Value Index is an unmanaged index of those companies in the broad-market Russell 3000® Index chosen for their value orientation. The Russell 3000® Value - Russell Midcap® Growth Linked Benchmark represents performance of the Russell 3000® Value Index through March 20, 2018 and performance of the Russell Midcap® Growth Index thereafter. You cannot invest directly in an index.
Consider these risks before investing: The value of investments in the fund's portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including general economic, political, or financial market conditions; investor sentiment and market perceptions; government actions; geopolitical events or changes; and factors related to a specific issuer, geography, industry, or sector. These and other factors may lead to increased volatility and reduced liquidity in the fund's portfolio holdings. Growth stocks may be more susceptible to earnings disappointments, technological obsolescence, falling prices and profits, and the market may not favor growth-style investing. Investments in small and midsize companies increase the risk of greater price fluctuations. International investing involves currency, economic, and political risks. Emerging-market securities have illiquidity and volatility risks. The fund's sustainable and environmental, social, and/or corporate governance (ESG) investment strategy may result in the fund investing in certain types of companies, industries or sectors that the market may not favor. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, which would make the fund more vulnerable to adverse developments affecting those industries or sectors. In evaluating an investment opportunity, we may make investment decisions based on information and data that is incomplete or inaccurate. Due to changes in the products or services of the companies in which the fund invests, the fund may temporarily hold securities that are inconsistent with its sustainable investment criteria. Our investment techniques, analyses, and judgments may not produce the outcome we intend. The investments we select for the fund may not perform as well as other securities that we do not select for the fund. We, or the fund's other service providers, may experience disruptions or operating errors that could have a negative effect on the fund. You can lose money by investing in the fund.